Omega Healthcare Investors, Inc. (NYSE:OHI) Stake Lowered by Pathway Financial Advisers LLC

Pathway Financial Advisers LLC lowered its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 88,349 shares of the real estate investment trust’s stock after selling 867 shares during the quarter. Omega Healthcare Investors makes up approximately 1.1% of Pathway Financial Advisers LLC’s holdings, making the stock its 28th largest position. Pathway Financial Advisers LLC’s holdings in Omega Healthcare Investors were worth $3,023,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in OHI. Centersquare Investment Management LLC grew its position in shares of Omega Healthcare Investors by 36.6% during the fourth quarter. Centersquare Investment Management LLC now owns 3,585,255 shares of the real estate investment trust’s stock worth $109,924,000 after acquiring an additional 960,997 shares during the last quarter. Daiwa Securities Group Inc. raised its holdings in shares of Omega Healthcare Investors by 1,030.8% during the second quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock valued at $32,384,000 after buying an additional 861,907 shares during the last quarter. Marshall Wace LLP acquired a new position in shares of Omega Healthcare Investors during the second quarter worth approximately $20,962,000. BROOKFIELD Corp ON bought a new position in Omega Healthcare Investors in the 1st quarter worth approximately $16,446,000. Finally, Verition Fund Management LLC raised its stake in Omega Healthcare Investors by 5,224.5% during the 4th quarter. Verition Fund Management LLC now owns 524,201 shares of the real estate investment trust’s stock valued at $16,072,000 after acquiring an additional 514,356 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Price Performance

NYSE:OHI opened at $40.69 on Tuesday. The firm has a market cap of $10.05 billion, a PE ratio of 36.66, a price-to-earnings-growth ratio of 1.32 and a beta of 1.00. The company’s 50-day moving average price is $38.81 and its two-hundred day moving average price is $34.40. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors, Inc. has a 12 month low of $27.53 and a 12 month high of $41.53.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm had revenue of $252.70 million during the quarter, compared to analyst estimates of $205.92 million. During the same quarter in the previous year, the business earned $0.74 earnings per share. Omega Healthcare Investors’s revenue for the quarter was up 17.5% compared to the same quarter last year. On average, equities analysts anticipate that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Monday, August 5th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 6.59%. The ex-dividend date was Monday, August 5th. Omega Healthcare Investors’s payout ratio is 241.44%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Mizuho cut Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their price target for the stock from $34.00 to $35.00 in a research note on Thursday, July 25th. Truist Financial boosted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Wells Fargo & Company upgraded shares of Omega Healthcare Investors to a “strong-buy” rating in a report on Friday, June 14th. Finally, Scotiabank boosted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a report on Monday, August 26th. Eight equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $34.89.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.